Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Polish Journal of Thoracic and Cardiovascular Surgery
eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2025
vol. 22
 
Share:
Share:
Original paper

Evolution of pulmonary artery reconstruction techniques: a focus on the neovalve from the right atrial appendage

Bobur Turaev
1
,
Nodir Ibragimov
1
,
Afzal Babaev
1
,
Yulduz Turaeva
1
,
Kambarali Khaydarov
1

  1. Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
Kardiochirurgia i Torakochirurgia Polska 2025; 22 (1): 14-19
Online publish date: 2025/03/17
Article file
Get citation
 
PlumX metrics:
 

Introduction

Pulmonary artery (PA) repair is a pivotal procedure in pediatric cardiac surgery, essential for addressing congenital heart defects that impair pulmonary circulation. Traditionally, the transannular patch (TAP) technique has been a standard approach for PA reconstruction, aimed at relieving obstruction and improving blood flow. However, this method is not without its drawbacks, particularly concerning postoperative right ventricular (RV) function and pulmonary valve (PV) insufficiency.

The use of TAP involves opening the pulmonary annulus along a commissure of the pulmonary artery and placing a patch to widen it, which can result in significant PV regurgitation and RV dysfunction. Studies have documented that TAP can lead to adverse outcomes such as RV dilatation and impaired RV function due to the loss of the valve’s dynamic role in regulating blood flow and pressure. For instance, a study by Kim et al. [1] highlighted that TAP was associated with increased risk of RV failure and reduced exercise capacity in pediatric patients, underscoring the need for alternative strategies to mitigate these risks.

In response to these challenges, innovative approaches have been explored to improve postoperative outcomes. One such technique is the use of the right atrial appendage (RAA) to construct a neovalve. This novel method has been shown to potentially mitigate some of the drawbacks associated with TAP by preserving more of the native valve’s function.

A landmark study by Amirghofran et al. [2] is among the first to report on the use of autologous RAA as a neovalve for PA repair in patients with tetralogy of Fallot. Their work, published in the European Journal of Cardio-Thoracic Surgery, demonstrated the feasibility and effectiveness of this technique. The authors provided valuable insights into the short- to mid-term outcomes of using the RAA neovalve, highlighting its potential benefits over traditional TAP methods. Their findings indicated improvements in RV function and a reduction in severe PV regurgitation, supporting the RAA neovalve as a viable alternative. Recent studies suggest that RAA neovalve construction may offer several benefits over traditional TAP.

Building on these promising results, our study aims to further investigate and compare the outcomes of PA repair using the RAA neovalve versus traditional TAP. By examining procedural metrics, RV function, and postoperative recovery, we seek to evaluate the relative benefits and limitations of these repair techniques. This research focuses on RV function, which is critical for postoperative recovery and long-term cardiac health.

Material and methods

Study design

This study is a retrospective cohort analysis conducted to compare the outcomes of PA repair using a neovalve constructed from the RAA versus TAP repair. The study focuses on evaluating key postoperative metrics, including RV function, procedural times, and recovery outcomes.

Patient selection

The study cohort included 16 pediatric patients who underwent PA repair between December 2023 and April 2024. Patients were divided into two groups based on the type of repair performed:

  • Group 1 (RAA valve): 8 patients who received a neovalve constructed from the RAA.

  • Group 2 (TAP): 8 patients who underwent traditional TAP repair.

Surgical technique

In the RAA valve group, the neovalve was constructed using a modified technique based on the method described by Amirghofran et al. [2]. After initiating cardiopulmonary bypass and achieving adequate myocardial protection, the PA was mobilized up to the bifurcation, ensuring clear exposure of the main PA. The RAA was carefully dissected while preserving its vascular supply and ensuring sufficient tissue for neovalve construction.

A longitudinal incision was made in the main PA and was extended across the annulus into the right ventricular outflow tract (RVOT) to assess the site of the obstruction or stenosis. The RAA was then tailored to create a cusp-like structure, mimicking the configuration of a native pulmonary valve. Sutures were placed along the edges of the RAA tissue and the incision in the PA to secure the neovalve in position, ensuring that the leaflet tissue provided adequate coaptation during systole and diastole. Particular care was taken to avoid tension or distortion of the RAA tissue.

The neovalve was tested intraoperatively by flushing saline through the PA to verify its competence and functionality. After ensuring satisfactory valve performance, the PA was reconstructed over the neovalve using autologous or synthetic patches as necessary. Hemostasis was meticulously achieved before weaning the patient off cardiopulmonary bypass.

For the TAP group, the standard transannular patch technique was employed to relieve the obstruction in the PA. Following exposure of the stenotic area, a longitudinal incision was extended across the annulus into the right ventricular outflow tract (RVOT). A patch, tailored from autologous pericardium or synthetic material, was sutured in place to widen the RVOT and PA. Postoperative echocardiography confirmed the patency of the reconstructed RVOT and PA.

Figures 1 and 2 illustrate the steps of the neovalve construction process and its intraoperative appearance.

Figure 1

Illustration of the procedure for constructing a pulmonary neovalve using the right atrial appendage

/f/fulltexts/KiTP/55780/KITP-22-55780-g001_min.jpg
Figure 2

Photographs depicting key steps of the surgical process for constructing a pulmonary neovalve using the right atrial appendage (A), along with an echocardiogram image of the neovalve (B)

/f/fulltexts/KiTP/55780/KITP-22-55780-g002_min.jpg

Data collection

Data were collected from medical records, including:

  • demographic information: age, sex, weight, height,

  • preoperative details: history of Blalock-Taussig (BT) shunt, PA annulus size, and Z-score,

  • procedural metrics: procedure time, bypass time, and aortic cross-clamp (ACC) time.

Postoperative outcomes: mortality, intensive care unit (ICU) stay, hospital stay, PV regurgitation, RV dysfunction, and RVOT peak gradient.

To ensure comparable groups and minimize selection and performance bias, we included 3 patients in the TAP group who had undergone a BT shunt via left thoracotomy approximately 1 year prior, matching the 3 patients in the RAA neovalve group who had also undergone the same procedure.

Outcome measures

The primary outcomes of interest included:

  • RV function: assessed through the presence and severity of RV dysfunction and RVOT peak gradient,

  • PV regurgitation: classified as no regurgitation, mild, moderate, or severe,

  • Recovery metrics: ICU stay and hospital stay duration.

Statistical analysis

All statistical analyses were performed using the Jamovi application. Continuous variables were compared using the independent t-test, while categorical variables were analyzed using the c2 test. Pearson’s correlation coefficient was used to assess the relationship between PV regurgitation and RV dysfunction. A p-value of < 0.05 was considered statistically significant.

Ethical considerations

This study was conducted as a retrospective cohort analysis. Given the nature of the study, which involved the review of existing medical records without direct patient intervention or interaction, informed consent was not required. The study was approved by the Institutional Ethics Committee of Tashkent Pediatric Medical Institute (#2, 25.03.2024y), which determined that the use of de-identified patient data for research purposes did not necessitate patient consent.

Results

The study included 16 pediatric patients undergoing PA repair, divided into two groups: those receiving the RAA valve (n = 8) and those undergoing traditional TAP (n = 8). Both groups were comparable in terms of age, sex distribution, weight, height, history of BT shunt, PA annulus size, and Z-score (Table I).

Table I

Patient demographic and clinical variables for the right atrial appendage (RAA) neovalve and transannular patch (TAP) groups

VariablesRAA valve (n = 8)TAP (n = 8)P-value
Age [months]19.8 ±4.221.3 ±5.40.547
Males (%)2 (25%)3 (37.5%)0.590
Weight [kg]10.8 ±1.4611.3 ±1.830.575
Height [cm]80.4 ±3.3481.5 ±4.380.572
After BT shunt (n)3 (37.5%)3 (37.5%)1
PA annulus size [mm]6.86 ±0.77.23 ±0.740.332
Z-score of PA annulus–3.46 ±0.715–3.29 ±0.4490.567

The average procedure time was longer in the RAA valve group (222 ±33.1 minutes) compared to the TAP group (196 ±16.7 minutes), but this difference was not statistically significant (p = 0.07). In contrast, the TAP group had a significantly shorter bypass time (126 ±6.48 minutes vs. 145 ±10.0 minutes, p < 0.001) and ACC time (86.6 ±3.7 minutes vs. 104 ±10.3 minutes, p < 0.001) compared to the RAA valve group (Table II).

Table II

Procedural metrics and postoperative outcomes for right atrial appendage (RAA) neovalve and transannular patch (TAP) groups

VariablesRAA valve (n = 8)TAP (n = 8)P-value
Procedure time [min]222 ±33.1196 ±16.70.07
Bypass time [min]145 ±10.0126 ±6.48< 0.001
ACC time [min]104 ±10.386.6 ±3.7< 0.001
Mortality (n)0 (0%)2 (25%)0.131
ICU stay [days]3.88 ±0.846.13 ±2.750.044
Hospital stay [days]10.1 ±1.2513.2 ±3.190.029
PV regurgitation:
 No dysfunction50
 Mild30
 Moderate05
 Severe03< 0.001
RV dysfunction
 No dysfunction40
 Mild42
 Moderate04
 Severe020.014
RVOT peak gradient [mm Hg]25.3 ±6.116.9 ±7.90.032

Postoperative outcomes showed that patients in the RAA valve group had significantly shorter ICU stays (3.88 ±0.84 days) and hospital stays (10.1 ±1.25 days) compared to those in the TAP group (ICU stay: 6.13 ±2.75 days, p = 0.044; hospital stay: 13.2 ±3.19 days, p = 0.029). The mortality rate was higher in the TAP group (25%), but this difference was not statistically significant (p = 0.131) (Figure 3).

Figure 3

Violin plots showing the distribution of intensive care unit and hospital stay durations for the right atrial appendage (RAA) neovalve (group 1) and transannular patch (TAP) groups (group 2)

/f/fulltexts/KiTP/55780/KITP-22-55780-g003_min.jpg

Regarding postoperative complications, the RAA valve group had significantly fewer instances of severe PV regurgitation compared to the TAP group. Specifically, all patients in the RAA valve group had no or mild regurgitation, whereas the TAP group had several patients with moderate to severe regurgitation (p < 0.001).

RV function was also notably better in the RAA valve group. More patients in this group had no RV dysfunction (4 patients) compared to the TAP group (none, p = 0.014). Additionally, the RAA valve group had a higher RVOT peak gradient (25.3 ±6.1 mm Hg) compared to the TAP group (16.9 ±7.9 mm Hg, p = 0.032), indicating a significant difference in RV outflow (Table II).

A significant positive correlation was found between PV regurgitation and RV dysfunction, with Pearson’s correlation coefficient (r) calculated at 0.726, indicating a strong relationship between these two variables (p < 0.001). This suggests that higher levels of PV regurgitation are associated with greater RV dysfunction in our cohort (Figure 4).

Figure 4

Correlation plot illustrating the relationship between pulmonary valve (PV) regurgitation and right ventricular (RV) dysfunction. Pearson’s correlation coefficient is indicated, with a significant correlation (r = 0.726, p < 0.001)

/f/fulltexts/KiTP/55780/KITP-22-55780-g004_min.jpg

Discussion

This study compares outcomes between PA repair using a neovalve constructed from the RAA and TAP repair. Our findings suggest that the RAA neovalve technique may offer several advantages over TAP, particularly regarding postoperative recovery and RV function. The RAA neovalve group showed significantly fewer cases of severe PV regurgitation and better RV function compared to the TAP group.

Traditional TAP repair has been a common approach for PA reconstruction, as it allows for adequate outflow tract size but is associated with significant postoperative complications. Previous studies [1, 3, 4] have documented that TAP is linked with a higher incidence of RV dysfunction and PV regurgitation. The chronic nature of these issues often necessitates further interventions and affects long-term outcomes. Alipour Symakani et al. [5] investigated RV function at the tissue level in patients after surgical correction of tetralogy of Fallot (ToF) and concluded that ‘as long as the long-term outcome of surgical correction of tetralogy of Fallot remains suboptimal, other treatment strategies need to be explored’. This underscores the importance of examining innovative methods, such as the RAA neovalve, to reduce RV dysfunction and address RVOT obstruction.

In contrast, the use of autologous tissues for valve reconstruction, as explored in recent studies, has shown promise in mitigating some of these complications. For instance, Amirghofran et al. [2] conducted one of the first comprehensive studies on using RAA for neovalve construction, demonstrating its potential to reduce PV regurgitation and improve RV function. Their findings indicate that the RAA neovalve can provide a more physiological valve replacement, which aligns with our results showing fewer severe PV regurgitation cases and improved RV function.

Other recent studies have also explored alternative techniques to address the limitations of TAP. For example, a study by Cocomello et al. [6] highlighted the benefits of using homograft valves and their impact on RV function and patient outcomes. Similarly, work by Abbas et al. [7] on various surgical techniques for RV outflow tract reconstruction underscored the importance of optimizing valve function to improve postoperative recovery.

In our study, while the RAA valve group had a longer procedure time compared to the TAP group, this difference was not statistically significant. However, the TAP group had significantly shorter bypass and aortic cross-clamp (ACC) times, which may reflect the procedural differences and complexity associated with RAA valve construction. Despite the longer procedural time, the RAA valve group demonstrated significantly shorter ICU and hospital stays. This advantage may be attributed to the lower incidence of severe PV regurgitation and better RV function observed in this group, which aligns with findings from studies such as those by Schulte et al. [8], who reported improved recovery outcomes with advanced valve repair techniques.

The significant correlation between PV regurgitation and RV dysfunction (r = 0.726, p < 0.001) observed in our study further emphasizes the critical impact of PV regurgitation on RV function. This finding aligns with previous research that highlighted the detrimental effects of severe PV regurgitation on RV performance. For instance, other authors [2, 8] also reported similar associations, suggesting that strategies to reduce PV regurgitation, such as the use of the RAA neovalve, could be pivotal in preserving RV function and improving postoperative outcomes. The strong correlation we found underscores the importance of minimizing PV regurgitation to prevent RV dysfunction, which is crucial for long-term patient prognosis.

Implications and future directions

The promising outcomes associated with the RAA neovalve technique suggest that using autologous tissue for valve reconstruction may offer a more physiological solution than traditional TAP. The improved RV function and reduced PV regurgitation observed in our study are consistent with the benefits reported in the literature. For example, research by Cocomello et al. [6] on autologous and bioprosthetic valves highlighted the potential for these approaches to reduce complications and improve functional outcomes.

Despite these encouraging results, our study is limited by its small sample size and retrospective design. Larger, prospective studies are needed to validate our findings and further assess the long-term benefits of the RAA neovalve technique. Future research should also focus on the impact of this technique on functional outcomes, quality of life, and the need for additional interventions.

Conclusions

The RAA neovalve technique for PA repair shows significant promise as an alternative to traditional TAP, with favorable outcomes related to RV function and postoperative recovery. The reduced incidence of severe PV regurgitation and improved recovery times underscore the potential advantages of using autologous tissue for valve reconstruction. As surgical techniques continue to evolve, the RAA neovalve may become a valuable option for improving outcomes in pediatric cardiac surgery.

Ethical approval

Approval number approved by the Institutional Ethics Committee of Tashkent Pediatric Medical Institute, #2, 25.03.2024.

Disclosure

The authors report no conflict of interest.

References

1 

Kim SJ, Li MH, Noh CI, Kim SH, Lee CH, Yoon JK. Impact of pulmonary arterial elastance on right ventricular mechanics and exercise capacity in repaired tetralogy of Fallot. Korean Circ J 2023; 53: 406-417.

2 

Amirghofran A, Edraki F, Edraki M, Ajami G, Amoozgar H, Mohammadi H, Emaminia A, Ghasemzadeh B, Borzuee M, Peiravian F, Kheirandish Z, Mehdizadegan N, Sabri M, Cheriki S, Arabi H. Surgical repair of tetralogy of Fallot using autologous right atrial appendages: short- to mid-term results. Eur J Cardiothorac Surg 2021; 59: 697-704.

3 

Eročlu AG, Sarioşlu A, Sariočlu T. Right ventricular diastolic function after repair of tetralogy of Fallot: its relationship to the insertion of a ‘transannular’ patch. Cardiol Young 1999; 9: 384-391.

4 

van der Ven JPG, van den Bosch E, Bogers AJCC, Helbing WA. Current outcomes and treatment of tetralogy of Fallot. F1000Res 2019; 8: F1000 Faculty Rev-1530.

5 

Alipour Symakani RS, van Genuchten WJ, Zandbergen LM, Henry S, Taverne YJHJ, Merkus D, Helbing WA, Bartelds B. The right ventricle in tetralogy of Fallot: adaptation to sequential loading. Front Pediatr 2023; 11: 1098248.

6 

Cocomello L, Meloni M, Rapetto F, Baquedano M, Ordoñez MV, Biglino G, Bucciarelli-Ducci C, Parry A, Stoica S, Caputo M. Long-term comparison between pulmonary homograft versus bioprosthesis for pulmonary valve replacement in tetralogy of Fallot. J Am Heart Assoc 2019; 8: e013654.

7 

Abbas JR, Hoschtitzky JA. Which is the best tissue valve used in the pulmonary position, late after previous repair of tetralogy of Fallot? Interact Cardiovasc Thorac Surg 2013; 17: 854-860.

8 

Schulte LJ, Miller PC, Bhat A, Carvajal-Dominguez HG, Chomat MR, Miller JR, Nath D, Eghtesady P. Evolution of pulmonary valve management during repair of tetralogy of fallot: a 14-year experience. Ann Thorac Surg 2023; 115: 462-469.

Copyright: © 2025 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.